Covington, Kentucky Clinical Trials

A listing of Covington, Kentucky clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 54 clinical trials
Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19)

The objectives of this study are to evaluate the safety, tolerability and efficacy of AT-527 in older subjects (ages 45-80 years) with moderate COVID-19 and risk factors for poor outcomes (such as obesity (BMI>30), hypertension, diabetes or asthma). Eligible subjects will be randomized to blinded AT-527 (nucleotide analog) tablets or …

SARS
coronavirus infection
acute respiratory syndrome (sars)
hypertension
covid-19
Atea Study Site
 (3.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.

life support
resuscitation
cardiac arrest
coma
induced hypothermia
University of Cincinnati
 (5.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +12 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

paclitaxel
pemetrexed
cisplatin/gemcitabine
carboplatin
monoclonal antibodies
Good Samaritan Hospital - Cincinnati
 (5.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +358 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

aphasia
progranulin
dementia
pick's disease
University Of Cincinnati Gardner Neuroscience institute
 (3.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

headache
ly573144
migraine
lasmiditan
treatment regimen
Cincinnati Childrens Hospital Medical Center
 (6.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +162 other locations
Cysteamine for Asthma

The purpose of this study is to see if a medicine called Cysteamine, given along with standard asthma care, will improve asthma symptoms and lung function.

skin prick
skin prick test
allergen
corticosteroids
rhinitis
Cincinnati Children's Hospital Medical Center
 (6.0 away) Contact site
  • 14 views
  • 16 Feb, 2024
  • 1 location
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)

Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram, followed by open-label naturalistic follow-up.

nuvaring
depo-provera
urine drug screen
depressive symptoms
citalopram
University of Cincinnati
 (3.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)

Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram, followed by double-blind, randomized adjunctive treatment with clonazepam or pregabalin for persistent symptoms.

nuvaring
depo-provera
urine drug screen
depression
citalopram
University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience
 (3.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Hyperpolarized Imaging for New Treatments

The introduction of triple combination CFTR modulator therapy for patients with Cystic Fibrosis (CF) with at least one copy of the deltaF508 mutation is expected to provide major health benefits, but will also require novel outcome measures that can detect CF lung disease at an early stage, capture the efficacy …

pulmonary disease
fibrosis
sweat chloride test
cystic fibrosis transmembrane conductance regulator
pulmonary function test
Cincinnati Children's Hospital Medical Center
 (6.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

stage iv non-small cell lung cancer
metastatic nsclc
pd-l1
egf receptors
epidermal growth factor
University of Cincinnati Cancer Institute /ID# 216800
 (3.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +38 other locations